Last reviewed · How we verify
NCT06161129: COMFORT
Filter Lenses for the Prevention of Migraine Attacks
NA trial testing Lenses in Migraine in 200 participants. Not yet recruiting.
31 August 2028
Quick facts
| Lead sponsor | Rune Skovgaard Rasmussen |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 200 |
| Start date | 1 March 2026 |
| Primary completion | 31 August 2028 |
| Estimated completion | 1 February 2029 |
| Sites | 1 location across Denmark |
Drugs / interventions tested
- Lenses
Conditions studied
- Migraine — all drugs for Migraine →
- Glasses — all drugs for Glasses →
- Headache — all drugs for Headache →
- Visual Impairment — all drugs for Visual Impairment →
Sponsor
Rune Skovgaard Rasmussen — full company profile →
Who can join
18 and older, any sex, with Migraine or Glasses. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose is to investigate whether the Blue Cut for Night filter is better at reducing migraine compared to the FL-41 filter or a filter blocking light below 500 nm. A control group will use clear lenses without filter. This is a controlled, randomized and double-blind trial.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06161129
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Lenses
Trials testing the same drug.
- NCT05477329 — CHILDREN MYOPIA CONTROL · NA · unknown
Other recruiting trials for Migraine
Currently open trials in the same condition.
- NCT07419607 — MIGRAFIT: Evaluating a Group Therapy Program Combining Physical Activity, Progressive Muscle Relaxation and Psychoeducat · NA · recruiting
- NCT07487701 — Migraine Prevention With the Remote Electrical Neuromodulation (REN) Wearable: A Real-world Evidence Study · NA · active not recruiting
- NCT07343427 — Impact of GON PRF on Central Sensitization in Migraine Patients · NA · active not recruiting
- NCT07336056 — Nerivio Efficacy Under High-Frequency Use · Phase 4 · active not recruiting
- NCT07385755 — Desvenlafaxine for Preventive Treatment of Frequent Migraines · NA · active not recruiting
Other Rune Skovgaard Rasmussen trials
Trials by the same sponsor.
- NCT07512323 — Effect of Testosterone on Elderly Frail Men With Testosterone Deficiency · Phase 2 · not yet recruiting
- NCT07135245 — Improved Treatment and Monitoring of Alzheimer's Disease · Phase 2 · not yet recruiting
- NCT06815692 — Interdisciplinary Interventions After mTBI · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06161129 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Rune Skovgaard Rasmussen
- Last refreshed: 9 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06161129.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing